247 related articles for article (PubMed ID: 29734196)
41. MicroRNA-15a Inhibits Proliferation and Induces Apoptosis in CNE1 Nasopharyngeal Carcinoma Cells.
Zhu K; He Y; Xia C; Yan J; Hou J; Kong D; Yang Y; Zheng G
Oncol Res; 2016; 24(3):145-51. PubMed ID: 27458095
[TBL] [Abstract][Full Text] [Related]
42. MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma.
Yi C; Wang Q; Wang L; Huang Y; Li L; Liu L; Zhou X; Xie G; Kang T; Wang H; Zeng M; Ma J; Zeng Y; Yun JP
Oncogene; 2012 Oct; 31(41):4421-33. PubMed ID: 22249270
[TBL] [Abstract][Full Text] [Related]
43. miR-135a Protects Dextran Sodium Sulfate-Induced Inflammation in Human Colorectal Cell Lines by Activating STAT3 Signal.
Zhang J; Lian B; Shang Y; Li C; Meng Q
Cell Physiol Biochem; 2018; 51(3):1001-1012. PubMed ID: 30476915
[TBL] [Abstract][Full Text] [Related]
44. [Effects of miR-135a on HOXA10 expression, proliferation and apoptosis of ovarian cancer cells].
Tang WW; Wan GP; Wan YC; Zhang L; Cheng WJ
Zhonghua Fu Chan Ke Za Zhi; 2013 May; 48(5):364-9. PubMed ID: 24016480
[TBL] [Abstract][Full Text] [Related]
45. miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion.
Xia H; Ng SS; Jiang S; Cheung WK; Sze J; Bian XW; Kung HF; Lin MC
Biochem Biophys Res Commun; 2010 Jan; 391(1):535-41. PubMed ID: 19931509
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma.
Cheung CC; Lun SW; Chung GT; Chow C; Lo C; Choy KW; Lo KW
BMC Cancer; 2016 Jul; 16():495. PubMed ID: 27431799
[TBL] [Abstract][Full Text] [Related]
47. Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.
Wu A; Wu K; Li J; Mo Y; Lin Y; Wang Y; Shen X; Li S; Li L; Yang Z
J Transl Med; 2015 Mar; 13():105. PubMed ID: 25884389
[TBL] [Abstract][Full Text] [Related]
48. Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A.
Du ZM; Hu LF; Wang HY; Yan LX; Zeng YX; Shao JY; Ernberg I
PLoS One; 2011 Apr; 6(4):e19137. PubMed ID: 21541331
[TBL] [Abstract][Full Text] [Related]
49. [miR-216b suppresses cell proliferation and invasion by targeting PKCα in nasopharyngeal carcinoma cells].
Deng M; Liu JF; Gu YX; Zheng GP; He ZM
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):645-50. PubMed ID: 24332049
[TBL] [Abstract][Full Text] [Related]
50. miR-184 Inhibits Tumor Invasion, Migration and Metastasis in Nasopharyngeal Carcinoma by Targeting Notch2.
Zhu HM; Jiang XS; Li HZ; Qian LX; Du MY; Lu ZW; Wu J; Tian XK; Fei Q; He X; Yin L
Cell Physiol Biochem; 2018; 49(4):1564-1576. PubMed ID: 30223264
[TBL] [Abstract][Full Text] [Related]
51. MiR-125b Increases Nasopharyngeal Carcinoma Radioresistance by Targeting A20/NF-κB Signaling Pathway.
Li LN; Xiao T; Yi HM; Zheng Z; Qu JQ; Huang W; Ye X; Yi H; Lu SS; Li XH; Xiao ZQ
Mol Cancer Ther; 2017 Oct; 16(10):2094-2106. PubMed ID: 28698199
[TBL] [Abstract][Full Text] [Related]
52. LncRNA FOXD3-AS1/miR-135a-5p function in nasopharyngeal carcinoma cells.
E Z; Li C; Xiang Y
Open Med (Wars); 2020; 15(1):1193-1201. PubMed ID: 33336076
[TBL] [Abstract][Full Text] [Related]
53. MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET.
Li YQ; Ren XY; He QM; Xu YF; Tang XR; Sun Y; Zeng MS; Kang TB; Liu N; Ma J
Cell Death Dis; 2015 Jan; 6(1):e1618. PubMed ID: 25611392
[TBL] [Abstract][Full Text] [Related]
54. Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients.
Li S; Hang L; Ma Y; Wu C
J Cell Mol Med; 2016 Dec; 20(12):2259-2268. PubMed ID: 27489139
[TBL] [Abstract][Full Text] [Related]
55. Minicircle-oriP-miR-31 as a Novel EBNA1-Specific miRNA Therapy Approach for Nasopharyngeal Carcinoma.
Wu J; Tan X; Lin J; Yuan L; Chen J; Qiu L; Huang W
Hum Gene Ther; 2017 May; 28(5):415-427. PubMed ID: 28042945
[TBL] [Abstract][Full Text] [Related]
56. Exosomal miR-24-3p impedes T-cell function by targeting FGF11 and serves as a potential prognostic biomarker for nasopharyngeal carcinoma.
Ye SB; Zhang H; Cai TT; Liu YN; Ni JJ; He J; Peng JY; Chen QY; Mo HY; Jun-Cui ; Zhang XS; Zeng YX; Li J
J Pathol; 2016 Nov; 240(3):329-340. PubMed ID: 27538493
[TBL] [Abstract][Full Text] [Related]
57. MiR-101 sensitizes human nasopharyngeal carcinoma cells to radiation by targeting stathmin 1.
Sun Q; Liu T; Zhang T; Du S; Xie GX; Lin X; Chen L; Yuan Y
Mol Med Rep; 2015 May; 11(5):3330-6. PubMed ID: 25607713
[TBL] [Abstract][Full Text] [Related]
58. miR-663 promotes NPC cell proliferation by directly targeting CDKN2A.
Liang S; Zhang N; Deng Y; Chen L; Zhang Y; Zheng Z; Luo W; Lv Z; Li S; Xu T
Mol Med Rep; 2017 Oct; 16(4):4863-4870. PubMed ID: 28765905
[TBL] [Abstract][Full Text] [Related]
59. miR‑495 enhances the efficacy of radiotherapy by targeting GRP78 to regulate EMT in nasopharyngeal carcinoma cells.
Feng X; Lv W; Wang S; He Q
Oncol Rep; 2018 Sep; 40(3):1223-1232. PubMed ID: 30015969
[TBL] [Abstract][Full Text] [Related]
60. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
